ALNY CIK: 1178670

Alnylam Pharmaceuticals, Inc.

  • United States
  • Healthcare
  • Biotech
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25
(positive)
Change from FY21 to FY25
billions USD
FY21:
0.73
FY22:
0.90
FY23:
1.56
FY24:
1.94
FY25:
3.04
(positive)
Change from FY21 to FY25
billions USD
FY21:
−0.71
FY22:
−0.79
FY23:
−0.28
FY24:
−0.18
FY25:
0.50
(positive)
Change from FY21 to FY25
billions USD
FY21:
−0.85
FY22:
−1.13
FY23:
−0.43
FY24:
−0.38
FY25:
0.32
(positive)
Change from FY21 to FY25
billions USD
FY21:
−0.85
FY22:
−1.13
FY23:
−0.44
FY24:
−0.28
FY25:
0.31

All amounts in billions USD Data source:SEC EDGAR